Yvonne Bankmann

Learn More
OBJECTIVE To assess the pharmacokinetics, safety profile, and efficacy of the fully human anti-tumor necrosis factor-alpha (anti-TNF-alpha) monoclonal antibody adalimumab (D2E7) in patients with long-standing, active rheumatoid arthritis (RA). METHODS This was a randomized, double blind, placebo controlled study of single intravenous injections of(More)
  • 1